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epidemiologic relationship between lead exposure and adiposity have been inconsistent (6, 7, 10) . Kim et al. (7) reported a positive association between lead exposure and body mass index (BMI) in a longitudinal study, whereas Scinicariello et al. (10) reported a negative association in adults. Our previously published crosssectional study also found that blood lead level (BLL) was positively associated with BMI (6) . Because this was a cross-sectional study, both directions were possible. Therefore, we tried to perform a Mendelian randomization (MR) analysis to exclude the causal effect of higher BMI on higher BLL. MR uses genetic variants associated with an intermediate phenotype (BMI) as instrumental variables (IVs) in nonexperimental data to make causal inferences about the effect of an exposure on an outcome (BLL) (11) . Because genetic variants are assumed to be randomly distributed within a population and exist before the outcome, the IV is regarded as independent of confounders affecting the exposureoutcome relationship and guiding the definite causal direction (12) . In this study, if higher BMI causally induces higher BLL, genetic variants associated with BMI could be expected to affect BLL.
Genetic and environmental interactions play pivotal roles in the development of overweight and obesity (13) . Environmental effects can differ between individuals depending on different genetic exposure levels because of gene-environment interactions. Previous genomewide association studies (GWASs) have identified many genetic loci to be associated with BMI and risk of obesity (13) . The genetic risk score (GRS) was often constructed to represent the genetic susceptibility based on multiple single nucleotide polymorphisms (SNPs) . Whether genetic factors modulate the association of BLL with BMI has not been studied. Thus, based on the large community-based sample of Chinese participants from the Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China) study (www. chictr.org.cn registration no. ChiCTR-ECS-14005052), we aimed to assess the association between BLL and BMI and then perform MR analyses to explore the causal effect of BMI on BLL. In particular, we constructed a BMI-GRS combining 29 BMI-related SNPs that were identified in GWASs either performed or validated in East Asians and examined the modification effect of the BMI-GRS on the association of BLL with BMI and overweight plus obesity (BMI $25 kg/m 2 ).
Methods

Study design and participants
The data were from the ongoing SPECT-China study, a cross-sectional investigation of the prevalence of metabolic diseases and risk factors in East China. Recruitment and enrollment have been described in detail (14, 15) . Chinese citizens $18 years old who had lived in their current area for $6 months were included. In 2014, 6899 subjects who were 18 to 93 years old were recruited to the SPECT-China study from 16 sites in Shanghai, Zhejiang Province, and Jiangxi Province. We excluded participants who were missing BMI data (n = 243), were missing BLL data (n = 1098), and were missing genotyping information ($9 SNPs) (n = 1646). A total of 3922 participants were involved in the final analyses (Fig. 1) .
The study protocol was approved by the Ethics Committee of Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the appropriate institutional review committee. Informed consent was obtained from all participants included in the study.
Procedures
A single assessment protocol was adopted during the interviews and collection of biological specimens at each study site. Blood samples were obtained between 7:00 AM and 10:00 AM after a fast of at least 8 hours. Blood was refrigerated immediately after phlebotomy, and after 2 to 4 hours it was centrifuged and the serum was aliquoted and frozen in a central laboratory. BLL and blood cadmium level were determined by atomic absorption spectrometry (BH2200, China). Glycated hemoglobin (HbA1c) was measured by high-performance liquid chromatography (MQ-2000PT; Medconn, Shanghai, China). Fasting plasma glucose, triglycerides, total cholesterol, and high-and low-density lipoprotein were measured by a Beckman Coulter AU 680 (Brea, CA). BMI was calculated as weight in kilograms divided by height in meters squared. Blood pressure was measured with standard methods, described previously (16) .
Diabetes was determined from a previous diagnosis by health care professionals, fasting plasma glucose level $7.0 mmol/L, or HbA1c $6.5%. Hypertension was assessed as systolic blood pressure $140 mm Hg, diastolic blood pressure $90 mm Hg, or self-reported previous diagnosis of hypertension by physicians. (14) . Current smoking was defined as having smoked at least 100 cigarettes in one's lifetime and currently smoking cigarettes (16) .
DNA was extracted from blood white cells with a blood genomic DNA extraction kit (DP603; Tiangen Biotech Co., Ltd., Beijing, China) on an automated nucleic acid extraction instrument (YOSE-S32; Tiangen Biotech Co., Ltd.). Specific assays were designed with the Geneious Pro (version 4.8.3; https://www.geneious.com/). Mass determination was carried out with the JUNO and data acquisition was used Fluidigm SNP Genotyping Analysis version 4.1.3 software (Fluidigm Corporation, South San Francisco, CA). Call rates of all SNPs were .98%.
For BMI, 35 SNPs were selected from genomewide association studies in East Asians (17) (18) (19) 
rs939584, PSME4 rs10208649, RGS7BP rs1035491, and LINC01392 rs143665886. Some of these SNPs were also used in previous mendelian analyses in Chinese (20) . Six SNPs (rs1907240, rs180950758, rs80234489, rs10208649, rs1035491, and rs143665886) were deleted because of deviation from the Hardy-Weinberg equilibrium with a P , 10 24 (Supplemental Table 1 ) (21) . There was no linkage disequilibrium relationship (r 2 = 0) between the remaining BMI SNPs (20) . The full list of SNPs is shown in Supplemental Table 1 (21) .
Statistical analysis
Data analyses were performed in IBM SPSS Statistics, version 22 (IBM Corporation, Armonk, NY). All analyses were two-sided. P , 0.05 indicated significance. Continuous variables were expressed as the mean 6 SD or median (interquartile range) and categorical variables as a percentage, respectively. BLL was natural-log transformed during regression analyses.
The additive genetic model for each SNP (coded as 0-2) was used to construct BMI-GRS. The score was defined as the sum of the number of BMI-increasing alleles at each locus multiplied by the respective b coefficient reported from the meta-analysis and a large GWAS in the Asian population (18, 19) . Those missing fewer than nine SNPs were imputed by the median number of each SNP. Twenty-three SNPs missed ,2% cases and five SNPs missed 5% to 10% of cases. Elaboration on how to calculate the BMI-GRS is shown in the Supplemental Material (21).
Main effects of BLL and weighted BMI-GRS on BMI (continuous variable) and weight status (BMI $25 kg/m 2 , categorical variable) were tested by linear and logistic regression analyses, respectively, with quartiles of BLLs and the weighted GRS, each 1-unit increment in lnBLL, and each 1-point increment in the score as the independent exposure. The model was adjusted for age, sex, economic status, rural/urban residence, current smoking, diabetes, hypertension, and dyslipidemia.
The GRS and BLL interactions were evaluated by putting BMI-GRS (continuous), lnBLL (continuous), and the multiplicative interaction term (BMI-GRS*BLL) in the same multivariable logistic regression model (22) . To visualize the interaction effect, stratified analyses were conducted in each quartile of BMI-GRS to examine the association of high BLL and lnBLL with weight status (BMI $25 kg/m 2 ). High BLL was defined as the upper quartile level of BLL. P , 0.0125 (0.05/4) was considered significant after adjustment of multiple comparisons.
We performed an MR analysis to exclude the causal effect of higher BMI on higher BLL. The association between BMI-GRS and measured BMI was measured by linear regression. To assess the reliability and strength of GRSs as instruments, the Fstatistic was adopted (F = [R 2 (n 2 2)]/(1 2 R 2 )) (23). F .10 indicates that the instrument is strong enough as an IV and R 2 is the proportion of variation in the respective phenotype explained by the genotype (24). Then we used regression analyses to calculate b coefficients for the association of BMI with lnBLL. Finally, we calculated IV estimates of genetically determined b coefficients with the Wald-type estimator (24, 25) . For the abnormal trend of BLL caused by increased BMI, the computational formula was b IV(BMI-lnBLL) = b BMI-GRS-lnBLL / b BMI-GRS-BMI . The SE and CI for the IV estimators was estimated by the delta method (26, 27) . The formulas were as follows:
Results
Characteristics of the participants by weight status
Of 3922 participants, 1252 (31.9%) were overweight and 223 (5.7%) were obese. Table 1 shows the characteristics of the participants by weight status. Among participants of normal weight, overweight, and obese, there was an increasing trend in age, BLL, BMI, BMI-GRS, and prevalence of diabetes, hypertension, and dyslipidemia. The median (interquartile range) of BLL was 39.0 (26.0 to 55.5) mg/L in participants with normal weight, 43.0 (28.5 to 61.2) mg/L in those who were overweight, and 43.6 (27.3 to 62.2) mg/L in those who were obese (P for trend , 0.05).
Main effect of BLL and BMI_GRS on BMI
The association of BLL and BMI-GRS with BMI and overweight (BMI $25 kg/m 2 ) is presented in Table 2 .
Multivariable regression analyses demonstrated significant associations between BLL (by BLL quartiles and continuous lnBLL) and BMI (P for trend , 0.001). Each unit increment in lnBLL corresponded to 0.24 kg/m 2 (95% CI, 0.08 to 0.40) increase in BMI. The BMI-GRS was also positively related to BMI (b = 0.08; 95% CI, 0.05 to 0.11 for each 1-point increase in GRS; P for trend , 0.001). The model was adjusted for age, sex, economic status, rural/urban residence, current smoking, diabetes, hypertension, and dyslipidemia.
The prevalence of overweight (BMI $25 kg/m 2 ) was 33.0%, 35.8%, 37.9%, and 43.7% for quartiles 1 to 4 of BLL. These results were similar to those above. According to logistic regression analyses, increasing BLL quartiles were positively related to BMI $25 kg/m 2 (P for trend , 0.01), with quartile 4 having the greatest OR, 1.40 (95% CI, 1.14 to 1.71). Weighted GRS was associated significantly with an increase in prevalence of overweight and obesity (OR 1.04; 95% CI, 1.02 to 1.06 for each 1-point increase in GRS; P for trend , 0.01). The data are summarized as the mean 6 SD or median (interquartile range) for continuous variables or as a numerical proportion for categorical variables. P for trend was calculated by ANOVA and x 2 tests.
Interaction effect of BMI-GRS and BLL exposure on BMI
The BMI-GRS modified the association of BLL exposure with BMI and overweight (BMI $25 kg/m 2 ) (P for interaction = 0.031 and 0.001, respectively; Table 2 ). To be more visually expressed, in the 4th quartile of BMI-GRS, compared with the participants with low BLL, those with high BLL had a greater prevalence of overweight (BMI $25 kg/m 2 ) (37.6% vs 51.7%, P = 0.003; Fig. 2A) . Each 1 unit of lnBLL was associated with 63% higher odds of abnormal weight status (OR 1.63; 95% CI, 1.30 to 2.05; Fig. 2B ) in the 4th GRS quartile. However, in the lower three GRS quartiles, no significant association was detected between higher lnBLL and abnormal weight status ( Fig. 2A and 2B) .
Furthermore, the interactions of single SNPs and BLLs on abnormal weight status were measured (Supplemental 
Association of BMI and BMI-GRS with BLL
The MR triangulation of BLL is shown in Fig. 3 . The F statistic of BMI-GRS was 36, indicating that it was sufficiently strong as an IV. A 1-kg/m 2 increase in measured BMI was significantly associated with lnBLL (b = 0.010; 95% CI, 0.003 to 0.016). However, BMI-GRS was not significantly associated with lnBLL (b = 22.1 3 10
24
; 95% CI, 20.006 to 0.006). In the IV analysis, the causal regression coefficient of a genetically determined 1-kg/m 2 higher BMI for lnBLL was 20.003 (96% CI, 20.075 to 0.070), which showed no significance.
Discussion
This study investigated the modification effect of BMI genetic susceptibility on adiposity in relation to lead exposure and used an MR design to measure the causal effect of BLL on adiposity. In this cross-sectional survey including~4000 community-dwelling Chinese adults, we found that higher BLL, an environmental endocrinedisrupting factor, was significantly associated with higher BMI and prevalence of overweight (BMI $25 kg/m 2 ). Under the MR design, the possibility that higher BMI led to higher BLL was unlikely, and thus the reverse causal direction, that higher BLL induced higher BMI, was more convincing. Furthermore, BMI-GRS significantly modulated the association between lead exposure and adiposity. 2 (overweight or obese) was significantly greater in high BLL in participants in the highest GRS quartile, whereas no difference was found between the prevalence of BMI $25 kg/m 2 and BLL in lower-GRS groups. P values were adjusted for age and sex. (B) The weight status of BMI $25 kg/m 2 was significantly associated with each 1-unit increase in lnBLL in subjects in the highest GRS quartile, whereas no association was found in lower-GRS groups. The model adjusted for age, sex, economic status, rural/urban residence, current smoking, diabetes, hypertension, and dyslipidemia. The P for interaction was tested by putting BMI_GRS quartiles (continuous variable), BLL (continuous variable), and the interaction term (BMI_GRS quartiles*BLL) in the same multivariable model.
BLL was significantly associated with abnormal weight (BMI $25 kg/m 2 ) only in participants with a higher BMI-GRS, whereas no associations were found in those who had a lower BMI-GRS.
Consistent with our finding, in a longitudinal study, a 10-fold increase in children's dentin lead level was associated with an increase in BMI of 1.02 kg/m 2 , and this effect persisted into young adulthood (7). However, based on data from the National Health and Nutrition Examination Survey for 1999 to 2006, another study found that compared with those in the lowest BLL quartile, adults in the highest BLL quartile were 58% less likely to be obese. Furthermore, in two other crosssectional studies, no association was found in adults (28, 29) . It is hard to explain clearly the differences. Confounders such as ethnicity, lead exposure type, and BLL may act jointly in the link between lead exposure and adiposity. Long-term cohort studies with large sample sizes would be necessary to elucidate effects of BLL on adiposity.
To make the causal effect of BLL on BMI more evident in our study, we used MR analyses to exclude the causal effect of BMI on BLL. However, we also genotyped the BLL-related SNPs (ALAD rs1805313 and ALAD rs8177800) according to a GWAS of European populations (30) . However, ALAD rs1805313 was not significantly associated with BLL in our population (P = 0.922). For ALAD rs8177800, there is only a GG genotype, no GA and AA in our study population. Thus, the causal direction from BLL to BMI could not be inferred by MR design currently. In MR, genetic variants are used as IVs to assess the causal effect of the exposure on the outcome. In our study, we used GRS instead of each SNP. To be an IV, a GRS should meet three assumptions (31) . First, the GRS should be associated with the exposure. All SNPs selected in this study have previously been shown to be significantly associated with BMI in a large GWAS. In our study, the association of the GRS with BMI was also significant. Second, the GRS should not be associated with any confounder of the exposure-outcome association. In this study, we found the GRS was associated with lipid profile and hypertension (Supplemental Table 3 ) (21). When we used the new GRS excluding SNPs associated with lipid profile and blood pressure, the results did not change. Third, the GRS should be independent of the outcome, except possibly through its association with the exposure. It means that the only causal route from the genetic variants to the outcome is through the exposure (31) . However, this is only an idealized view and quite untestable, especially when the result is negative. Three BMI-related SNPs (rs11671664, rs261967, and rs3932549) showed significant association with lnBLL. A GRS excluding these three SNPs also did not change the results.
Interestingly, we found that the BMI-GRS significantly modified the association of BLL with overweight (BMI $25 kg/m 2 ). Because the soaring prevalence of obesity over the last few decades indicates that there must be a strong environmental impact on adiposity, many studies have explored the specific environmental factors that could interact with obesity-predisposing genes (32, 33) . Various aspects have been explored, including obesity-predisposing gene variants interacting with pregnancy and in utero factors, age, physical activity, diet, psychosocial stress, and even bariatric surgery (32) . In the present study, we showed that BLL was associated with overweight and obesity in participants with higher GRSs, but the association was not significant in those with lower GRSs. These data indicate that the underlying mechanisms of the association of BLL with adiposity may differ according to the individual's obesity-predisposing genetic background.
The mechanisms of the interaction between the obesity-predisposing genetic variants and BLL were not clarified. It has been well established that lead plays a role as a neurotoxin (34) , and obesity and brain function are also closely related (35) . One mechanism may involve the effects of metal neurotoxicity on brain function and signaling related to appetite and satiety (36) ; this mechanism has been reviewed (37) . When the interactions of single SNPs and BLLs on abnormal weight status were measured, Krüppel-like factor 9 (KLF9), brain-derived neurotrophic factor (BDNF), and paired box protein 6 (PAX6) loci showed marginal interaction effects. Larger samples may be needed in the future to confirm the interaction effect of single SNPs, especially the three brain development-associated SNPs. We found that only a few of the identified susceptibility genes for adiposity were related to the brain, and lead exposure might exert a different effect on brain function related to obesity under different genetic variations. Another mechanism may involve gut microbiota. Animal models found that prenatal lead exposure could alter gut microbiota and lead to body weight gain (38) . Thus, the gut microbiota-brain axis may be a breakthrough point to understand the potential mechanism of lead exposure in relation to body weight.
Our study had some strengths. This study combined cross-sectional and MR design to detect the association between BLL and adiposity in Chinese and first used the Asian-specific BMI-GRS as the modification factor to examine the gene-BLL interaction. Second, our recruited population was community dwelling, with a large sample size, so our finding is more representative than that of a clinic-based population. Third, this study has strong quality control because, by using the same anthropometric measurement method and questionnaire, the same trained research group completed all the investigations at each site. However, our study also has some limitations. First, because of its cross-sectional nature, we cannot infer a causal relationship between BLL and BMI. However, we used MR analyses to exclude the causal effect of BMI on BLL to make the inference of a BLL effect on BMI more convincing. Second, all participants were of Asian origin, so the data may not be generalizable to other ethnic groups. Third, we developed our GRS based only on common variants among Asians in consideration, which was considered to represent limited BMI heritability, and still many loci with boundary relations with BMI or undetected ones are missed. Fourth, this study tested only the multiplicative interaction but not additive interaction, and thus any conclusion by additive interaction could be obtained.
Conclusions
Better understanding of the interaction between genetic and environmental factors is the basis for developing effective personalized obesity prevention and management strategies. In the present community-based study, we found that BLL was positively associated with BMI and adiposity, and we were inclined to exclude the possibility that higher BMI induced higher BLL by MR analyses. Furthermore, BMI-GRS based on 29 common variations in Asians modified the associations of BLL with adiposity after adjustment for demographic factors, diabetes, hypertension, and lipid profile. Future longterm cohort studies with larger sample sizes are necessary to further confirm the causal effect of lead exposure on adiposity and elucidate the roles of lead exposure in the pathogenesis of obesity.
